Why the study?
Do tricyclic antidepressants cause dose-related cardiotoxicity in children and adults?
Do tricyclic antidepressants cause dose-related cardiotoxicity in children and adults?
Tricyclic antidepressants can cause dose-related cardiotoxicity, including arrhythmias and sudden death, prompting caution against using higher-than-recommended dosages.
Answers are grounded in this paper and cite their sources.
Supports dose-dependent TCA cardiotoxicity caution; leaves open precise contemporary risk estimates and monitoring thresholds.
THE FOOD and Drug Administration (FDA) recently convened a conference of experts to review the question of cardiotoxicity of tricyclic antidepressant (TCA) drugs.¹The main impetus for this meeting was concern over reports of changes detected in the electrocardiograms (ECGs) of children receiving imipramine hydrochloride at a dosage of 5 mg/kg²,³and of the sudden death of a child receiving a single bedtime dose of imipramine hydrochloride, 14.7 mg/ kg, for school phobia.⁴There is also evidence that TCAs given in therapeutic dosages alter myocardial function in adult patients⁵and occasionally produce heart block and tachyrhythmias in patients with a normal cardiovascular history.⁶⁻¹¹ The present concern stems from an increasing tendency of some physicians to employ higher-than-recommended dosages. Although arrhythmias do occur at standard dosages, the evidence suggests that the likelihood of producing substantial alteration in the ECG and cardiac arrhythmia is dose-related.⁶,⁸,¹⁰Thus,
No takes yet. Share an insight, caveat, or question.
Donald S. Robinson (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: